Eurofins CDMO
Planegg, DE · San Diego, CA
Compare Biologics CDMOs in Europe
Compare Biologics CDMOs in Germany
Compare Cell Therapy CDMOs in Europe
Compare Cell Therapy CDMOs in Germany
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
81.6
Signal Score
✓ FDA Inspections (7)
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: Eurofins CDMO
- Signal Score
- 81.6/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100 — Bonus: 4 consecutive NAI inspections
- Headquarters
- Planegg, DE · San Diego, CA
- Modalities
- Biologics, Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Eurofins CDMO
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Bonus: 4 consecutive NAI inspections
Sources: FDA Data Dashboard
Bonus: 4 consecutive NAI inspections
FDA Inspections7 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2026-05-15)
Bonus: 4 consecutive NAI inspections
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
68.0
Parent company: Eurofins Scientific
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Eurofins Scientific
Financial assessment: 68.0/100
Capacity
63.0
2 manufacturing sites
Sites: Planegg, DE, San Diego, CA
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals8 articles (not scored)
2 manufacturing sites
Eurofins CDMO FDA Inspection History
2026-05
2025-12
2025-06
2025-03
2024-07
2023-06
2023-02
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2026-05-15 |
Eurofins Donor & Product Testing, Inc.
Honolulu, Hawaii
Company-level
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2025-12-12 |
Eurofins Donor & Product Testing, LLC
Philadelphia, Pennsylvania
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2025-06-27 |
Eurofins Donor & Product Testing Inc.
Winston Salem, North Carolina
Company-level
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2025-03-26 |
Eurofins Donor & Product Testing, LLC
Irwindale, California
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2024-07-19 |
Eurofins Donor & Product Testing LLC
Centennial, Colorado
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Not posted | Voluntary Action Indicated (VAI) |
| 2023-06-09 |
Eurofins Donor & Product Testing, Inc.
Honolulu, Hawaii
Company-level
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2023-02-17 |
Eurofins Donor & Product Testing, LLC
Philadelphia, Pennsylvania
Facility-linked
|
Vaccines and Allergenic Products | Not posted | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source:
smartrecruiters
· Checked Nov 20, 2026
Company Signals 8 articles
Company announcements, not verified evidence. They do not change any score.
Dr. Kirithivasan Venkatesan Appointed as Senior Director – Process R&D at Eurofins CDMO India - hrtoday.in
Dr. Kirithivasan Venkatesan Appointed as Senior Director – Process R&D at Eurofins CDMO India hrtoday.in
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - BioSpace
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing BioSpace
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Business Wire
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing Business Wire
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Bluefield Daily Telegraph
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing Bluefield Daily Telegraph
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Yahoo Finance
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing Yahoo Finance
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - The Manila Times
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study The Manila Times
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ... - Caledonian Record
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ... Caledonian Record
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - Bitget
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study Bitget
Frequently Asked Questions About Eurofins CDMO
How many FDA inspections does Eurofins CDMO have on record?
CDMO Signal tracks 7 FDA inspections for Eurofins CDMO, sourced from the FDA inspection database. See the full inspection history above.
Has Eurofins CDMO received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Eurofins CDMO.
What is Eurofins CDMO's CDMO Signal Score?
Eurofins CDMO has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating Eurofins CDMO for a manufacturing program?
Use the free AI matchmaker to compare Eurofins CDMO against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
ProBio
Pennington, NJ · Nanjing, CN
Signal Score: 64.0
mRNA, Biologics, CAR-T, Cell Therapy
Syngene International
Bengaluru, India
Signal Score: 80.3
Biologics, Cell Therapy
Singota Solutions
Bloomington, IN
Signal Score: 59.0
Cell Therapy, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 90.1
Biologics, mRNA, Small Molecule API, Oral Solid Dose, High-Potency APIs, Sterile Fill-Finish
Compare Eurofins CDMO with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.